BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18237145)

  • 1. Chemical properties and toxicity of chromium(III) nutritional supplements.
    Levina A; Lay PA
    Chem Res Toxicol; 2008 Mar; 21(3):563-71. PubMed ID: 18237145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity of chromium(III) nutritional supplements in biological media: an X-ray absorption spectroscopic study.
    Nguyen A; Mulyani I; Levina A; Lay PA
    Inorg Chem; 2008 May; 47(10):4299-309. PubMed ID: 18433095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trivalent chromium: assessing the genotoxic risk of an essential trace element and widely used human and animal nutritional supplement.
    Eastmond DA; Macgregor JT; Slesinski RS
    Crit Rev Toxicol; 2008; 38(3):173-90. PubMed ID: 18324515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA.
    Speetjens JK; Collins RA; Vincent JB; Woski SA
    Chem Res Toxicol; 1999 Jun; 12(6):483-7. PubMed ID: 10368310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-ray absorption and EPR spectroscopic studies of the biotransformations of chromium(VI) in mammalian cells. Is chromodulin an artifact of isolation methods?
    Levina A; Harris HH; Lay PA
    J Am Chem Soc; 2007 Feb; 129(5):1065-75. PubMed ID: 17263387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual reactivity in a commercial chromium supplement compared to baseline DNA cleavage with synthetic chromium complexes.
    Chaudhary S; Pinkston J; Rabile MM; Van Horn JD
    J Inorg Biochem; 2005 Mar; 99(3):787-94. PubMed ID: 15708800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of trivalent chromium complexes: no evidence for DNA damage in human HaCaT keratinocytes.
    Hininger I; Benaraba R; Osman M; Faure H; Marie Roussel A; Anderson RA
    Free Radic Biol Med; 2007 Jun; 42(12):1759-65. PubMed ID: 17512455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromium(III) complexes inhibit transcription factors binding to DNA and associated gene expression.
    Raja NS; Nair BU
    Toxicology; 2008 Sep; 251(1-3):61-5. PubMed ID: 18706470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nonmutagenic Cr(III)-DNA interactions.
    Blankert SA; Coryell VH; Picard BT; Wolf KK; Lomas RE; Stearns DM
    Chem Res Toxicol; 2003 Jul; 16(7):847-54. PubMed ID: 12870887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the nutritional biochemistry of trivalent chromium.
    Vincent JB
    Proc Nutr Soc; 2004 Feb; 63(1):41-7. PubMed ID: 15070438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for combined inorganic, biochemical, and nutritional studies of chromium(III).
    Vincent JB; Love ST
    Chem Biodivers; 2012 Sep; 9(9):1923-41. PubMed ID: 22976981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity studies of chromium(III) complexes on human dermal fibroblasts.
    Shrivastava HY; Ravikumar T; Shanmugasundaram N; Babu M; Unni Nair B
    Free Radic Biol Med; 2005 Jan; 38(1):58-69. PubMed ID: 15589372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the potential for developmental toxicity of prenatal exposure to two dietary chromium supplements, chromium picolinate and [Cr3O(O2CCH2CH3)(6(H2O)3]+, in mice.
    Bailey MM; Sturdivant J; Jernigan PL; Townsend MB; Bushman J; Ankareddi I; Rasco JF; Hood RD; Vincent JB
    Birth Defects Res B Dev Reprod Toxicol; 2008 Feb; 83(1):27-31. PubMed ID: 18076115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenic Chromium(VI) Compounds Formed by Intracellular Oxidation of Chromium(III) Dietary Supplements by Adipocytes.
    Wu LE; Levina A; Harris HH; Cai Z; Lai B; Vogt S; James DE; Lay PA
    Angew Chem Int Ed Engl; 2016 Jan; 55(5):1742-5. PubMed ID: 26696553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromium toxicity in plants.
    Shanker AK; Cervantes C; Loza-Tavera H; Avudainayagam S
    Environ Int; 2005 Jul; 31(5):739-53. PubMed ID: 15878200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium: celebrating 50 years as an essential element?
    Vincent JB
    Dalton Trans; 2010 Apr; 39(16):3787-94. PubMed ID: 20372701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of ligand structure in DNA/protein binding, mutagenicity, excision repair and nutritional aspects of chromium(III) complexes.
    Vaidyanathan VG; Asthana Y; Nair BU
    Dalton Trans; 2013 Feb; 42(7):2337-46. PubMed ID: 23247426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung cells: intracellular mapping of the biotransformation products of a chromium carcinogen.
    Dillon CT; Lay PA; Kennedy BJ; Stampfl AP; Cai Z; Ilinski P; Rodrigues W; Legnini DG; Lai B; Maser J
    J Biol Inorg Chem; 2002 Jun; 7(6):640-5. PubMed ID: 12072970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incision of trivalent chromium [Cr(III)]-induced DNA damage by Bacillus caldotenax UvrABC endonuclease.
    O'Brien TJ; Jiang G; Chun G; Mandel HG; Westphal CS; Kahen K; Montaser A; States JC; Patierno SR
    Mutat Res; 2006 Nov; 610(1-2):85-92. PubMed ID: 16890479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary chromium loss associated with diabetes is offset by increases in absorption.
    Rhodes NR; McAdory D; Love S; Di Bona KR; Chen Y; Ansorge K; Hira J; Kern N; Kent J; Lara P; Rasco JF; Vincent JB
    J Inorg Biochem; 2010 Jul; 104(7):790-7. PubMed ID: 20417571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.